Top compounds associated with response to MT1F


Feature Type Standardized
Nominal ANOVA
mRNA tacedinaline CTRPv2 pan-cancer AAC 0.085 0.02
mRNA JQ-1:MK-0752 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.077 0.02
mRNA tanespimycin:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.084 0.03
mRNA navitoclax:PLX-4032 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.079 0.03
mRNA navitoclax:pluripotin (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.081 0.03
mRNA necrostatin-1 CTRPv2 pan-cancer AAC 0.081 0.03
mRNA dacarbazine CTRPv2 pan-cancer AAC 0.071 0.03
mRNA selumetinib:JQ-1 (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.075 0.03
mRNA PRL-3 Inhibitor I CTRPv2 pan-cancer AAC -0.084 0.03
mRNA momelotinib CTRPv2 pan-cancer AAC 0.076 0.03
Download CSV